Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection - PubMed (original) (raw)
Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection
Barbara L Shacklett et al. J Virol. 2003 May.
Abstract
Gut-associated lymphoid tissue (GALT) is a significant but understudied lymphoid organ, harboring a majority of the body's total lymphocyte population. GALT is also an important portal of entry for human immunodeficiency virus (HIV), a major site of viral replication and CD4(+) T-cell depletion, and a frequent site of AIDS-related opportunistic infections and neoplasms. However, little is known about HIV-specific cell-mediated immune responses in GALT. Using lymphocytes isolated from rectal biopsies, we have determined the frequency and phenotype of HIV-specific CD8(+) T cells in human GALT. GALT CD8(+) T cells were predominantly CD45RO(+) and expressed CXCR4 and CCR5. In 10 clinically stable, chronically infected individuals, the frequency of HIV Gag (SL9)-specific CD8(+) T cells was increased in GALT relative to peripheral blood mononuclear cells by up to 4.6-fold, while that of cytomegalovirus (CMV)-specific CD8(+) T cells was significantly reduced (P = 0.012). Both HIV- and CMV-specific CD8(+) T cells in GALT expressed CCR5, but only HIV-specific CD8(+) T cells expressed alpha E beta 7 integrin, suggesting that mucosal priming may account for their retention in GALT. Chronically infected individuals exhibited striking depletion of GALT CD4(+) T cells expressing CXCR4, CCR5, and alpha E beta 7 integrin, but CD4(+)/CD8(+) T-cell ratios in blood and GALT were similar. The percentage of GALT CD8(+) T cells expressing alpha E beta 7 was significantly decreased in infected individuals, suggesting that HIV infection may perturb lymphocyte retention in GALT. These studies demonstrate the feasibility of using tetramers to assess HIV-specific T cells in GALT and reveal that GALT is the site of an active CD8(+) T-cell response during chronic infection.
Figures
FIG. 1.
CD4+/CD8+ T-cell ratios in blood and GALT. Values were determined by four-color flow cytometry. Results shown are for 5 healthy controls (left) and 10 HIV-positive individuals (right). Linear regression analysis was used to generate lines and curves with a 95% confidence interval.
FIG. 2.
Phenotype of GALT CD8+ T cells. PBMC and GALT from HIV-positive individuals and controls (not shown) were stained with monoclonal antibodies to the αβ T-cell receptor (top left), CD45RO isoform (top right), CD69 antigen (bottom left), and CD25 (bottom right). The results shown are gated on CD8+ T cells and are typical of those for HIV-positive patients and controls. Grey lines indicate PBMC, and black lines indicate GALT cells.
FIG. 3.
MHC class I tetramer staining of HIV- and CMV-specific CD8+ T cells from blood and GALT. (A) Representative results for an HIV-positive individual. Plots are gated on CD3+ lymphocytes. Numbers in the upper right corner of each plot represent the percentage of CD8+ T cells bound by HLA-A*0201-HIV Gag SL9 (left) or CMV pp65 (right) tetramers. (B) Combined results of MHC class I tetramer staining for peripheral blood and GALT from 10 HLA-A*0201-positive, HIV-infected individuals. Each patient is represented by a different symbol, and lines between symbols identify PBMC and GALT samples from a single individual.
FIG. 4.
Expression of β7 integrins in blood and GALT. (A) Expression of integrins α4β7 and αΕβ7 on CD4+ and CD8+ T cells from blood and GALT of HIV-negative (top) and HIV-positive (bottom) individuals. Numbers indicate the percentage of CD4+ or CD8+ lymphocytes in each quadrant. (B) Mean (bar height) and standard deviation (error bars) α4β7 and αΕβ7 levels for HIV-infected individuals and controls as stated in the text. Top, α4β7 expression. ∗, P = 0.014 for blood CD8+ T cells from six HIV-positive versus two HIV-negative individuals. Bottom, αΕβ7 expression. ∗ and ∗∗, P = 0.003 for GALT CD4+ T cells and P = 0.004 for GALT CD8+ T cells, respectively, from six HIV-positive versus four HIV-negative individuals.
FIG. 5.
Expression of CXCR4 and CCR5 in blood and GALT. (A) Expression of chemokine receptors CXCR4 and CCR5 on CD4+ and CD8+ T cells from blood and GALT of HIV-negative (top) and HIV-positive (bottom) individuals. Numbers indicate the percentages of CD4+ or CD8+ lymphocytes in each quadrant. (B) Mean (bar height) and standard deviation (error bars) values for HIV-infected individuals and controls as stated in the text. ∗∗, P < 0.001 for GALT CD4+ T cells expressing CXCR4+ and CCR5+ from seven HIV-positive versus three HIV-negative individuals.
FIG. 6.
Antigen-specific CD8+ T cells express lymphocyte trafficking markers. (A) Expression of CCR5 by HIV Gag (left)- and CMV (right)-specific CD8+ T cells in blood and GALT of patient G04. (B) Expression of αΕβ7 integrin by HIV Gag (left)- and CMV (right)-specific CD8+ T cells in blood and GALT of patient G25. (C) Expression of αΕβ7 integrin by CMV-specific CD8+ T cells in blood and GALT of patient G05.
Similar articles
- Isolation of cytomegalovirus-specific cytotoxic T-lymphocytes from gut-associated lymphoid tissue (GALT) of HIV type 1-infected subjects.
Shacklett BL, Beadle TJ, Pacheco PA, Grendell JH, Haslett PA, King AS, Ogg GS, Basuk PM, Nixon DF. Shacklett BL, et al. AIDS Res Hum Retroviruses. 2000 Aug 10;16(12):1157-62. doi: 10.1089/088922200415009. AIDS Res Hum Retroviruses. 2000. PMID: 10954891 - Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, McNeil A, Dandekar S. Guadalupe M, et al. J Virol. 2003 Nov;77(21):11708-17. doi: 10.1128/jvi.77.21.11708-11717.2003. J Virol. 2003. PMID: 14557656 Free PMC article. - Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects.
Shacklett BL, Beadle TJ, Pacheco PA, Grendell JH, Haslett PA, King AS, Ogg GS, Basuk PM, Nixon DF. Shacklett BL, et al. Virology. 2000 May 10;270(2):317-27. doi: 10.1006/viro.2000.0299. Virology. 2000. PMID: 10792991 - [Deep lung--cellular reaction to HIV].
Tavares Marques MA, Alves V, Duque V, Botelho MF. Tavares Marques MA, et al. Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Rev Port Pneumol. 2007. PMID: 17492233 Review. Portuguese. - [Key role played by the gut associated lymphoid tissue during human immunodeficiency virus infection].
Vergnon-Miszczycha D, Lucht F, Roblin X, Pozzetto B, Paul S, Bourlet T. Vergnon-Miszczycha D, et al. Med Sci (Paris). 2015 Dec;31(12):1092-101. doi: 10.1051/medsci/20153112012. Epub 2015 Dec 16. Med Sci (Paris). 2015. PMID: 26672662 Review. French.
Cited by
- An in vitro study to elucidate the effects of product Nkabinde on immune response in peripheral blood mononuclear cells of healthy donors.
Setlhare B, Letsoalo M, Nkabinde SA, Nkabinde M, Mzobe G, Mtshali A, Parveen S, Ngcobo S, Invernizzi L, Maharaj V, Ngcobo M, Gqaleni N. Setlhare B, et al. Front Pharmacol. 2024 Mar 12;15:1308913. doi: 10.3389/fphar.2024.1308913. eCollection 2024. Front Pharmacol. 2024. PMID: 38533263 Free PMC article. - CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair.
Jasinska AJ, Pandrea I, Apetrei C. Jasinska AJ, et al. Front Immunol. 2022 Jan 27;13:835994. doi: 10.3389/fimmu.2022.835994. eCollection 2022. Front Immunol. 2022. PMID: 35154162 Free PMC article. Review. - Human mucosal tissue-resident memory T cells in health and disease.
Lange J, Rivera-Ballesteros O, Buggert M. Lange J, et al. Mucosal Immunol. 2022 Mar;15(3):389-397. doi: 10.1038/s41385-021-00467-7. Epub 2021 Nov 6. Mucosal Immunol. 2022. PMID: 34743182 Free PMC article. Review. - Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection.
Labarta-Bajo L, Nilsen SP, Humphrey G, Schwartz T, Sanders K, Swafford A, Knight R, Turner JR, Zúñiga EI. Labarta-Bajo L, et al. J Exp Med. 2020 Dec 7;217(12):e20192276. doi: 10.1084/jem.20192276. J Exp Med. 2020. PMID: 32880630 Free PMC article. - Delayed gastrointestinal-associated lymphoid tissue reconstitution in duodenum compared with rectum in HIV-infected patients initiating antiretroviral therapy.
Sainz T, Serrano-Villar S, Mann S, Ma ZM, Utay NS, Thompson CG, Chun TW, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Moreno S, Pollard RB, Landay A, Miller CJ, Asmuth DM. Sainz T, et al. AIDS. 2019 Dec 1;33(15):2289-2298. doi: 10.1097/QAD.0000000000002361. AIDS. 2019. PMID: 31764094 Free PMC article. Clinical Trial.
References
- Agace, W. W., J. M. Higgins, B. Sadasivan, M. B. Brenner, and C. M. Parker. 2000. T-lymphocyte-epithelial-cell interactions: integrin alpha(E)(CD103)beta(7), LEEP-CAM and chemokines. Curr. Opin. Cell Biol. 12:563-568. - PubMed
- Agace, W. W., A. I. Roberts, L. Wu, C. Greineder, E. C. Ebert, and C. M. Parker. 2000. Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation. Eur. J. Immunol. 30:819-826. - PubMed
- Anton, P. A., J. Elliot, M. A. Poles, I. M. McGowan, J. Matud, L. E. Hultin, K. Grovit-Ferbas, C. R. Mackay, I. S. Y. Chen, and J. V. Giorgi. 2000. Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue. AIDS 14:1761-1765. - PubMed
- Belyakov, I. M., J. D. Ahlers, B. Y. Brandwein, P. Earl, B. L. Kelsall, B. Moss, W. Strober, and J. A. Berzofsky. 1998. The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. J. Clin. Investig. 102:2072-2081. - PMC - PubMed
- Betts, M. R., J. P. Casazza, B. A. Patterson, S. Waldrop, W. Trigona, T. M. Fu, F. Kern, L. J. Picker, and R. A. Koup. 2000. Putative immunodominant human immunodeficiency virus-specific CD8+ T-cell responses cannot be predicted by major histocompatibility complex class I haplotype. J. Virol. 74:9144-9151. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- P30-AI27763/AI/NIAID NIH HHS/United States
- R21 NS-44976/NS/NINDS NIH HHS/United States
- R01 NS044976/NS/NINDS NIH HHS/United States
- P30 AI027763/AI/NIAID NIH HHS/United States
- R21 AI-47746/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials